191 related articles for article (PubMed ID: 32472705)
1. Successful treatment with dupilumab of an adult with Netherton syndrome.
Andreasen TH; Karstensen HG; Duno M; Lei U; Zachariae C; Thyssen JP
Clin Exp Dermatol; 2020 Oct; 45(7):915-917. PubMed ID: 32472705
[No Abstract] [Full Text] [Related]
2. Successful treatment of Netherton syndrome with dupilumab: A case report and review of the literature.
Wang J; Yu L; Zhang S; Wang C; Li Z; Li M; Zhang S
J Dermatol; 2022 Jan; 49(1):165-167. PubMed ID: 34862657
[TBL] [Abstract][Full Text] [Related]
3. A compound synonymous mutation c.474G>A with p.Arg578X mutation in SPINK5 causes splicing disorder and mild phenotype in Netherton syndrome.
Numata S; Teye K; Krol RP; Okamatsu Y; Hashikawa K; Matsuda M; Fortugno P; Di Zenzo G; Castiglia D; Zambruno G; Hamada T; Hashimoto T
Exp Dermatol; 2016 Jul; 25(7):568-70. PubMed ID: 26997095
[No Abstract] [Full Text] [Related]
4. A case of Netherton syndrome with mutation in SPINK5 and FLG.
Shi ZR; Xu M; Tan GZ; Wang L; Guo Q; Tang ZQ
Eur J Dermatol; 2017 Oct; 27(5):536-537. PubMed ID: 28943498
[No Abstract] [Full Text] [Related]
5. Novel SPINK5 variants in a patient with Netherton syndrome and intellectual disability. The diagnostic value of trichoscopy.
Schepis C; Failla P; Siragusa M; Vinci M; Calì F
G Ital Dermatol Venereol; 2020 Apr; 155(2):239-240. PubMed ID: 29781262
[No Abstract] [Full Text] [Related]
6. A case of Netherton syndrome with intestinal atresia, a novel SPINK5 mutation, and a fatal course.
Nevet MJ; Indelman M; Ben-Ari J; Bergman R
Int J Dermatol; 2017 Oct; 56(10):1055-1057. PubMed ID: 28832989
[No Abstract] [Full Text] [Related]
7. Treatment of Netherton syndrome with dupilumab.
Odorici G; Schenetti C; Marzola E; Monti A; Borghi A; Corazza M
J Dtsch Dermatol Ges; 2022 Dec; 20(12):1636-1640. PubMed ID: 36321361
[No Abstract] [Full Text] [Related]
8. Successful infliximab treatment in siblings with Netherton syndrome: Unveiling a novel SPINK5 gene variant and literature review.
Salici NS; Ozcanli A; Rasulova G; Basak AN; Tekgul S; Vural S
Australas J Dermatol; 2024 May; 65(3):e45-e49. PubMed ID: 38419182
[TBL] [Abstract][Full Text] [Related]
9. Response to dupilumab in two children with Netherton syndrome: Improvement of pruritus and scaling.
Süßmuth K; Traupe H; Loser K; Ständer S; Kessel C; Wittkowski H; Oji V
J Eur Acad Dermatol Venereol; 2021 Feb; 35(2):e152-e155. PubMed ID: 32810299
[No Abstract] [Full Text] [Related]
10. SPINK5 mutation and FLG gene deletion in an infant with Netherton syndrome.
Hacıhamdioğlu DÖ; Altan Ferhatoğlu Z; Karkucak M; Fişek İzci NM; Yakut T
Pediatr Int; 2022 Jan; 64(1):e15087. PubMed ID: 35438212
[No Abstract] [Full Text] [Related]
11. Treatment of Netherton Syndrome With Dupilumab.
Steuer AB; Cohen DE
JAMA Dermatol; 2020 Mar; 156(3):350-351. PubMed ID: 31995125
[No Abstract] [Full Text] [Related]
12. Dupilumab in paediatric Netherton syndrome: Can we do better?
Herzum A; Occella C; Gariazzo L; Formigoni C; Viglizzo G
Australas J Dermatol; 2023 Aug; 64(3):e305-e307. PubMed ID: 37279014
[No Abstract] [Full Text] [Related]
13. Two siblings affected by Netherton/Comèl syndrome. Diagnostic pathology and description of a new SPINK5 variant.
Schepis C; Siragusa M; Centofanti A; Vinci M; Calì F
Dermatol Online J; 2019 Jul; 25(7):. PubMed ID: 31450277
[TBL] [Abstract][Full Text] [Related]
14. Desquamating Rash in a Patient with Undiagnosed Netherton Syndrome.
De Niear MA; Gigante J
J Pediatr; 2018 Jan; 192():262-262.e1. PubMed ID: 29106927
[No Abstract] [Full Text] [Related]
15. Netherton syndrome: Temporary response to dupilumab.
Aktas M; Salman A; Apti Sengun O; Comert Ozer E; Hosgoren Tekin S; Akin Cakici O; Demir G; Ergun T
Pediatr Dermatol; 2020 Nov; 37(6):1210-1211. PubMed ID: 32951242
[TBL] [Abstract][Full Text] [Related]
16. New compound heterozygous SPINK5 mutations in a Chinese infant with Netherton syndrome.
Wang Q; Qiu F; Wu H; Fan YM
J Eur Acad Dermatol Venereol; 2021 Nov; 35(11):e782-e784. PubMed ID: 34138484
[No Abstract] [Full Text] [Related]
17. LEKTI domains D6, D7 and D8+9 serve as substrates for transglutaminase 1: implications for targeted therapy of Netherton syndrome.
Wiegmann H; Valentin F; Tarinski T; Liebau E; Loser K; Traupe H; Oji V
Br J Dermatol; 2019 Nov; 181(5):999-1008. PubMed ID: 30801672
[TBL] [Abstract][Full Text] [Related]
18. A novel SPINK5 donor splice site variant in a child with Netherton syndrome.
Mintoff D; Borg I; Vornweg J; Mercieca L; Merdzanic R; Numrich J; Aquilina S; Pace NP; Fischer J
Mol Genet Genomic Med; 2021 Mar; 9(3):e1611. PubMed ID: 33534181
[TBL] [Abstract][Full Text] [Related]
19. Netherton syndrome: A neonatal case with respiratory insufficiency.
Okulu E; Tunc G; Erdeve O; Mumcu Y; Atasay B; Ince E; Arsan S
Arch Argent Pediatr; 2018 Aug; 116(4):e609-e611. PubMed ID: 30016041
[TBL] [Abstract][Full Text] [Related]
20. A Netherton syndrome case report: Response to dupilumab treatment.
Galdo G; Fania L
Dermatol Ther; 2022 Nov; 35(11):e15862. PubMed ID: 36175157
[No Abstract] [Full Text] [Related]
[Next] [New Search]
